Both medications are notorious for causing nausea, but clinical studies and patient feedback are split on which is worse
Wegovy is an FDA-approved brand of semaglutide, administered as an injection, and belongs to a class of medications known as GLP-1 receptor agonists
In a 68-week clinical trial, participants receiving the recommended semaglutide maintenance dose (2.4 mg) lost an average of nearly 15% of their starting body weight, with about half of the participants losing 15% or more of their body weight
That Jennifer Hardy Nov 1, 202510 min read Scent of a GLP-1 User: 5 Ways Body Odor Can Change Most people taking GLP-1s are well aware of the potential benefits and risks of side effects
[1] [2] Anesthesiologists may employ risk mitigation strategies including rapid sequence induction, cricoid pressure, use of medications to reduce gastric acidity (proton pump inhibitors, H2-blockers), and consideration of point-of-care gastric ultrasound to assess residual gastric volume